These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12792864)

  • 1. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci.
    Miyoshi-Akiyama T; Zhao J; Kikuchi K; Kato H; Suzuki R; Endoh M; Uchiyama T
    J Infect Dis; 2003 Jun; 187(12):1876-87. PubMed ID: 12792864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
    Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.
    Shiseki M; Miwa K; Nemoto Y; Kato H; Suzuki J; Sekiya K; Murai T; Kikuchi T; Yamashita N; Totsuka K; Ooe K; Shimizu Y; Uchiyama T
    Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
    Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
    Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.
    Stevens DL; Salmi DB; McIndoo ER; Bryant AE
    J Infect Dis; 2000 Oct; 182(4):1117-28. PubMed ID: 10979908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters.
    Byrne JL; Aagaard-Tillery KM; Johnson JL; Wright LJ; Silver RM
    J Reprod Immunol; 2009 Oct; 82(1):74-83. PubMed ID: 19682751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and distribution of Streptococcus pyogenes type M in patients treated at the Dr. Fran Mihaljević Infectious Disease Clinic in Zagreb from 1990 to 1996].
    Bejuk D; Begovac J
    Acta Med Croatica; 2002; 56(3):85-91. PubMed ID: 12630338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
    Eriksson BK; Andersson J; Holm SE; Norgren M
    J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate.
    Miyoshi-Akiyama T; Ikebe T; Watanabe H; Uchiyama T; Kirikae T; Kawamura Y
    J Infect Dis; 2006 Jun; 193(12):1677-84. PubMed ID: 16703511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of pyrogenic exotoxin SpeA, SpeB and SpeC genes in Chilean streptococci isolates and their association with clinical manifestations].
    Ulloa MT; Giglio MS; Porte L; Santa Cruz A; McNab P; Fica A; Pinto ME; Kawaguchi K; Carmi A
    Rev Med Chil; 2000 Jan; 128(1):27-34. PubMed ID: 10883519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.
    Unnikrishnan M; Cohen J; Sriskandan S
    Microb Pathog; 2001 Sep; 31(3):109-14. PubMed ID: 11500096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
    Woischnik M; Buttaro BA; Podbielski A
    Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray.
    Vlaminckx BJ; Schuren FH; Montijn RC; Caspers MP; Fluit AC; Wannet WJ; Schouls LM; Verhoef J; Jansen WT
    Infect Immun; 2007 May; 75(5):2603-11. PubMed ID: 17325055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Invasive Lancefield group A streptococcal infections in the Netherlands].
    Vlaminckx BJ; Mascini EM; Schellekens JF
    Ned Tijdschr Geneeskd; 2007 Jul; 151(30):1669-73. PubMed ID: 17725254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
    Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
    mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection.
    Engleberg NC; Heath A; Miller A; Rivera C; DiRita VJ
    J Infect Dis; 2001 Apr; 183(7):1043-54. PubMed ID: 11237829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
    Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
    J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of metabolic substances produced by group A streptococcus from a food-borne epidemic.
    Kanno T; Sakaguchi K; Fukuyama M; Suzuki J
    J Infect Chemother; 2011 Aug; 17(4):462-7. PubMed ID: 21190121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of NAD
    Velarde JJ; O'Seaghdha M; Baddal B; Bastiat-Sempe B; Wessels MR
    mBio; 2017 Sep; 8(5):. PubMed ID: 28900022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of streptolysin O in cytolysin-mediated translocation.
    Meehl MA; Caparon MG
    Mol Microbiol; 2004 Jun; 52(6):1665-76. PubMed ID: 15186416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.